
difference in
retreatment rates
between UGFS for GSV
and SSV reï¬‚ux or
between UGFS for
primary or recurrent
disease

Turtulici,222
2017

37 patients with recurrent disease

RFA

none

SFJ and perforator
treatment failure at 1
year was 17% and 23%

Prospective

Theivacumar,
20082